December 2024 Newsletter: Season’s greetings from Pharmalys! ✨

Dec 23, 2024 | Newsletters

Dear all, 2024 has been a year of growth and exciting developments for Pharmalys and the Pharmalys Academy of Clinical research Excellence (PACE).
Among the highlights, Pharmalys expanded its reach with new international clients and projects, while welcoming new team members across Business Operations, Capacity Building, Clinical Operations, Finance, and Strategic Projects.
The PACE pilot cohort, launched in 2023, concluded this year with a memorable graduation ceremony held in Dakar. The event brought together notable clinical research stakeholders, including Professors of medicine, a representative from the Mastercard Foundation, as well as graduates’ families and friends.
We also conducted several capacity-building trainings for clinical research professionals, including members of Ethics Committees and Regulatory Bodies. Our work extended to auditing numerous clinical research laboratories as part of the GCLP Accreditation Scheme.
Additionally, we hosted the recent Clinical Research Excellence and Development Opportunity (CREDO) webinar on Implementation Research, featuring leading experts in the field and attracting 136 participants. Throughout the year, we continued to strengthen our culture of quality, enhancing our standards across all areas of work.
Looking ahead to 2025, we are eager to embrace new challenges and pursue ambitious goals. We’ll be sharing videos showcasing events from Pharmalys and PACE, as well as highlights from the CREDO webinar. Our commitment remains steadfast in providing high-level scientific and medical information while advancing efforts to sustain and develop the clinical research ecosystem wherever it is needed.

We wish you all a joyful and restful holiday season and a prosperous start to the new year!

To be continued….

16 Days of Activism 2025: A Call to End Gender-Based Violence

16 Days of Activism 2025: A Call to End Gender-Based Violence

From 25 November to 10 December each year, the global community highlights the 16 Days of Activism Against Gender-Based Violence – a period dedicated to raising awareness, driving action and engaging all sectors of society to prevent and respond to violence rooted in...

Celebrating a Milestone in GCLP Compliance!

Celebrating a Milestone in GCLP Compliance!

We are thrilled to announce the successful completion of the initial GCLP accreditation audit at Hararghe Health Research Laboratory, Haramaya University College of Health and Medical Sciences, Harar, Ethiopia. The audit took place on 16–17 October 2025 and marked a...

Movember 2025: Raising Awareness for Men’s Health

Movember 2025: Raising Awareness for Men’s Health

November often signals the start of the festive season in many places, but for men’s health it holds a special significance: Movember. This annual campaign invites men (and those who support them) to pause, reflect and act on several critical health issues that too...

Highlights from the final Pharmalys Voice Meeting of 2025

Highlights from the final Pharmalys Voice Meeting of 2025

On September 25, 2025, Pharmalys held its third and final Pharmalys Voice meeting of the year, bringing together colleagues from across the company in a fun and interactive virtual gathering. The meeting involved presentations from colleagues, engaging discussions,...

Ethiopia Reaches WHO Maturity Level 3

Ethiopia Reaches WHO Maturity Level 3

On 3 October 2025, Dr Mekdes Daba, Health Minister of Ethiopia, announced a major achievement for the country: the formal recognition of the Ethiopian Food and Drug Authority (EFDA) as a Maturity Level 3 (ML3) regulatory system by the World Health Organization (WHO)....

Breast Cancer Awareness 2025: Access and Awareness Saves Lives

Breast Cancer Awareness 2025: Access and Awareness Saves Lives

Breast cancer remains the most common cancer among women worldwide. In the United States, statistics suggest that one in eight women will receive a diagnosis in her lifetime. In 2025 alone, it is estimated that 316,950 women and 2,800 men will be diagnosed with...